McLane J A, Katz M, Abdelkader N
Preclinical Research, Roche Dermatologics, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
In Vitro Cell Dev Biol. 1990 Apr;26(4):379-87. doi: 10.1007/BF02623829.
1,25-Dihydroxyvitamin D3 (1,25-(OH)2-D3) is known to decrease the proliferation and increase the differentiation of different cell types including human keratinocytes. The growth and differentiation of keratinocytes in the presence of 1,25-(OH)2-D3 using serum-free media formulations has been described previously. This investigation extends these studies to describe various culture conditions with human foreskin keratinocytes to determine the optimal antiproliferative activity of 1,25-(OH)2-D3. Keratinocytes were plated onto tissue culture dishes using one of three basic serum-free media protocols; a) with no feeder layer in keratinocyte growth medium (KGM); b) onto mitomycin C-treated 3T3 mouse embryo fibroblasts; or c) onto mitomycin C-treated dermal human fibroblasts. The last two protocols utilized Dulbecco's modified Eagle's Medium (DMEM) supplemented with growth factors. Keratinocyte cell growth was greatest in the KGM medium. Although the growth of keratinocytes on either feeder layer was similar, there were differences in the ability of the cells to form envelopes in the presence of 1,25-(OH)2-D3. The addition of hydrocortisone and cholera toxin to the medium also affected the response of the keratinocytes to 1,25-(OH)2-D3. The antiproliferative effect of 1,25-(OH)2-D3 was not altered by varying the extracellular calcium levels from 0.25 to 3 mM. The antiproliferative activity of 1,25-(OH)2-D3 is attenuated in cells at low density. Our results suggest that an optimal condition to investigate the ability of 1,25-(OH)2-D3 to inhibit keratinocyte proliferation is at preconfluent cell density in the presence of KGM supplemented with 1.5 mM calcium without a feeder layer. These conditions are not appropriate for investigating the enhancement of differentiation by 1,25-(OH)2-D3, but can be used to assay other agents that modulate keratinocyte proliferation.
已知1,25 - 二羟维生素D3(1,25-(OH)2-D3)可减少包括人角质形成细胞在内的不同细胞类型的增殖并促进其分化。此前已有研究描述了在无血清培养基配方存在下,1,25-(OH)2-D3对角质形成细胞生长和分化的影响。本研究扩展了这些研究,以描述用人包皮角质形成细胞的各种培养条件,从而确定1,25-(OH)2-D3的最佳抗增殖活性。角质形成细胞使用三种基本无血清培养基方案之一接种到组织培养皿中:a)在角质形成细胞生长培养基(KGM)中无饲养层;b)接种到经丝裂霉素C处理的3T3小鼠胚胎成纤维细胞上;或c)接种到经丝裂霉素C处理的人真皮成纤维细胞上。后两种方案使用补充了生长因子的杜尔贝科改良伊格尔培养基(DMEM)。角质形成细胞在KGM培养基中的生长最为旺盛。尽管角质形成细胞在两种饲养层上的生长相似,但在1,25-(OH)2-D3存在下细胞形成包膜的能力存在差异。向培养基中添加氢化可的松和霍乱毒素也会影响角质形成细胞对1,25-(OH)2-D3的反应。将细胞外钙水平从0.25 mM变化到3 mM不会改变1,25-(OH)2-D3的抗增殖作用。1,25-(OH)2-D3在低密度细胞中的抗增殖活性减弱。我们的结果表明,研究1,25-(OH)2-D3抑制角质形成细胞增殖能力的最佳条件是在预汇合细胞密度下,在补充有1.5 mM钙且无饲养层的KGM存在下。这些条件不适用于研究1,25-(OH)2-D3对分化的促进作用,但可用于检测其他调节角质形成细胞增殖的试剂。